U.S. pharma big copyright scrapped two experimental weight loss tablets past 12 months—a as soon as-everyday tablet, lotiglipron, as a consequence of elevated liver enzymes plus a 2 times-every day pill, danuglipron, as a result of powerful Negative effects—but CEO Albert Bourla has said the company is set to “Participate in and acquire” du